Tag: Kidney Problems: Misc.

Some Black medication users reclassified to lower eGFR for which dose adjustment or discontinuation is recommended

In addition, steeper decline in eGFR within one year associated with higher dementia risk

SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure

Maximum reduction in sedentary duration and increase in number of steps/day seen at week 20, attenuated by week 24

Patients in eKidneyCare group had fewer total medication discrepancies and a reduction in severity of discrepancies

69.5 percent of adults with CKD eligible for BP lowering according to 2021 KDIGO guideline versus 49.8 percent with 2012 guideline

Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year

Among patients who have in-hospital acute kidney injury, those with AKI tied to COVID-19 have faster rate of decrease in eGFR after discharge

High physical activity level (7.5 to <15 MET hours/week) linked to lower risks for all-cause mortality, ESRD, MACE

Adding eGFR, urinary albumin-to-creatinine ratio increases C statistic for risk prediction in overall population, those with diabetes